(Z)-hex-3-enyl acetate

Acute Toxicity: inhalation

Administrative data

Endpoint:

acute toxicity: inhalation

Type of information:

experimental study

Adequacy of study:

key study

Study period:

The study was performed between 19 September 2012 and 08 November 2012

Reliability:

1 (reliable without restriction)

Rationale for reliability incl. deficiencies:

other: GLP guideline study

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2013

Report date:

2013

Materials and methods

Test guideline

Qualifier:

according to guideline

Guideline:

OECD Guideline 436 (Acute Inhalation Toxicity: Acute Toxic Class Method)

GLP compliance:

yes (incl. QA statement)

Test type:

acute toxic class method

Limit test:

yes

Test material

Test material information

Constituent 1

Reference substance name:

(Z)-hex-3-enyl acetate

EC Number:

222-960-1

EC Name:

(Z)-hex-3-enyl acetate

Cas Number:

3681-71-8

Molecular formula:

C8H14O2

IUPAC Name:

(Z)-hex-3-enyl acetate

Details on test material:

- Name of test material (as cited in study report): (z)-hex-3-enyl acetate (LEAC)
- Physical state: clear colourless liquid
- Analytical purity: 98.45 %
- Lot/batch No.: 1Z00151
- Expiration date of the lot/batch: 13 June 2015
- Storage condition of test material: room temperature, in the dark

Test animals

Species:

rat

Strain:

other: RccHan™: WIST

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: Harlan Laboratories Ltd UK Ltd, Oxon, UK
- Age at study initiation: 8 - 12 weeks
- Weight at study initiation: 200 g - 360* g (* = Due to availability, one male animal was outside the weight range specified in the study plan (200- 350g). This deviation was considered not to affect the purpose or validity of the study)
- Housing: groups of 3 by sex in solid-floor polypropylene cages with stainless steel lids, furnished with softwood flakes
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: at least 5 d

ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19- 25
- Humidity (%): 30- 70
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12

Administration / exposure

Route of administration:

inhalation: mist

Type of inhalation exposure:

nose only

Details on inhalation exposure:

GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: cylindrical exposure chamber. The concentration within the exposure chamber was controlled by adjusting the rate of the infusion pump. The extract from the exposure chamber passed through a ‘scrubber’ trap and was connected with a high efficiency filter to a metered exhaust system. The chamber was maintained under negative pressure
- Exposure chamber volume: 30 L
- Method of holding animals in test chamber: Prior to the day of exposure each rat was acclimatised (for approximately 2 h) to a tapered polycarbonate restraining tube. During the day of exposure, each rat was individually held in a tapered, polycarbonate restraining tube fitted onto a single tier of the exposure chamber and sealed by means of a rubber ‘O’ ring.
- Source and rate of air: Compressed air was supplied by means of an oil free compressor and passed through a water trap and respiratory quality filters before it was introduced to the nebuliser.
- System of generating particulates/aerosols: The test item was aerosolised using a glass concentric jet nebuliser located at the top of the exposure chamber. The nebuliser was connected to a plastic syringe attached to an infusion pump, which provided a continuous supply of test item under pressure, and to a metered compressed air supply.
- Temperature, humidity: 20 °C, 72-74 %
- Oxygen concentration: Oxygen levels within the exposure chamber were measured by an electronic oxygen analyser located in a port in the animals breathing zone during the 4-h exposure period. The test atmosphere was generated to contain at least 19% oxygen

TEST ATMOSPHERE
- Brief description of analytical method used: GC analyis
- Samples taken from breathing zone: yes; the test atmosphere was sampled 5 times during the exposure period

TEST ATMOSPHERE
- Particle size distribution: The particle size of the generated atmosphere inside the exposure chamber was determined 3 times during the exposure period using a Marple Personal Cascade. This device consisted of 6 impactor stages (8.6, 5.5, 3.8, 1.7, 0.86 and 0.41 μm cut points) with stainless steel collection substrates and a back up glass fibre filter, housed in an aluminium sampler. The sampler was temporarily sealed in a sampling port in the animals’ breathing zone and a suitable, known volume of exposure chamber air was drawn through it using a vacuum pump. The collection substrates and backup filter were weighed before and after sampling and the weight of test item, collected at each stage, calculated by difference. The mean amount for each stage was used to determine the cumulative amount below each cut-off point size. In this way, the proportion (%) of aerosol less than 8.6, 5.5, 3.8, 1.7, 0.86 and 0.41 μm was calculated. The resulting values were converted to probits and plotted against Log10 cut-point size. From this plot, the Mass Median Aerodynamic Diameter (MMAD) was determined (as the 50% point) and the geometric standard deviation was calculated. In addition the proportion (%) of aerosol less than 4 μm (considered to be the inhalable fraction) was determined.
- MMAD (Mass median aerodynamic diameter) / GSD (Geometric st. dev.): 1.78 µm/ 3.02
- Predicted amount less than 4 µm: 76.9 %

CLASS METHOD
- Rationale for the selection of the starting concentration: A target concentration of 5.0 mg/L was used for the exposure. As the mean achieved concentration was 118% of target and no deaths occurred, no further levels were required.

Analytical verification of test atmosphere concentrations:

yes

Duration of exposure:

4 h

Concentrations:

A target concentration of 5.0 mg/L was used for the exposure.

No. of animals per sex per dose:

3/ sex/ dose

Control animals:

no

Details on study design:

- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: clinical signs, all animals were observed for clinical signs at hourly intervals during exposure, immediately on removal from the restraining tubes at the end of exposure, 1 h after termination of exposure and subsequently once daily for 14 d. Any evidence of overt toxicity was recorded at each observation; body weight,individual bodyweights were recorded on arrival, prior to treatment on the day of exposure and on Days 1,3, 7 and 14
- Necropsy of survivors performed: yes, at the end of the 14 d observation period all animals were killed by intravenous overdose of sodium pentobarbitone. All animals were subjected to a full external and internal examination, and any macroscopic abnormalities were recorded. The respiratory tract was subjected to a detailed macroscopic examination for signs of irritancy or local toxicity

Results and discussion

Effect levels

Sex:

male/female

Dose descriptor:

LC50

Effect level:

> 5.92 mg/L air

Based on:

test mat.

Exp. duration:

4 h

Mortality:

There were no mortalities.

Clinical signs:

other: One day after exposure, all animals exhibited increased respiratory rate, hunched posture and pilo-erection. Animals recovered to appear normal from Days 5 to 7 postexposure.

Body weight:

All male animals and 1 female exhibited slight bodyweight losses or showed no bodyweight gain on the first day post-exposure. Bodyweight gains were noted in all animals during the remainder of the recovery period, with the exception of 1 female animal which exhibited a bodyweight loss from Days 1 to 3 and showed no bodyweight gain from Days 3 to 7 post-exposure.

Gross pathology:

No macroscopic abnormalities were detected amoungst animals at necropsy.

Any other information on results incl. tables

Exposure Chamber Concentration

The actual concentration of the test item was measured off-line by Gas Chromatography (GC). The test atmospheres were sampled after theoretical chamber equilibration and then at approximately hourly intervals during the exposure period. The mean values obtained were:

Atmosphere concentration
Mean achieved (mg/L)	Standard deviation	Nominal (mg/L)
5.92	0.64	8.39

The chamber flow rate was maintained at 60 L/min providing 120 air changes per hour. The theoretical chamber equilibration time (T99) was 3 min* (* = The test atmosphere was generated for a total of 30 minutes prior to animal insertion to ensure test item concentration was being achieved.)

Particle Size Distribution

The particle size analysis of the atmosphere drawn from the animals’ breathing zone, was as follows:

Mean achieved atmosphere concentration (mg/L)	Mean mass median aerodynamic diameter (µm)	Inhalable fraction (5 <4 µm)	Geometric standard deviation
5.92	1.78	76.9	3.02

The GSD is out of the target range that would generally be acceptable for this type of study (1.5 – 3.0). This deviation was very slight (+ 0.02) and is considered to be due to the physical characteristics of the test item. However, as the particle size distributions are far lower than 4μm this is extremely small deviation to the test guideline is considered not to affect the purpose or validity of this study.

Applicant's summary and conclusion

Interpretation of results:

not classified

Remarks:

Migrated information Criteria used for interpretation of results: EU

Conclusions:

The acute toxicity of the test item was assessed via the inhalation route according to OECD guideline 436. No deaths occured in a group of 6 rats exposed to the mean acheived concentration of 5.92 mg/L for 4 h. Therefore, the acute inhalation median lethal concentration (4 h LC50) of the test item in the RCCHan™:WIST strain rat was greater than 5.92 mg/L.